Ontology highlight
ABSTRACT:
SUBMITTER: Abdelmotilib H
PROVIDER: S-EPMC5649055 | biostudies-other | 2017 Oct
REPOSITORIES: biostudies-other
Abdelmotilib Hisham H West Andrew B AB
Genome medicine 20171019 1
Increases in α-synuclein protein expression are suspected to increase the risk of the development of Parkinson's disease (PD). A recent study has demonstrated that β2-adrenergic receptor (β2AR) agonists decrease histone acetylation in the α-synuclein gene and suppress transcription. Coupled with the anti-inflammatory effects that are associated with β2AR activation, this two-pronged attack holds promise for PD treatment and the development of new therapeutic approaches for this disease. ...[more]